Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Oct;29(4):973-976.
doi: 10.3350/cmh.2023.0367. Epub 2023 Sep 18.

Adding to the confusion in more than just the name

Jacob George  1
Affiliations
Editorial

Adding to the confusion in more than just the name

Jacob George. Clin Mol Hepatol. 2023 Oct.
No abstract available

Keywords: Fatty liver disease; MAFLD; MASLD; Metabolic steatohepatitis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

The author has no conflicts to disclose but there might be perceived conflicts as stated in ICJME form.

Advisory board of NovoNordisk, Gilead, Roche, Abbvie, Astra zenica, Boehringer-ingelheim.

Comment on

References

    1. Eslam M, Sanyal AJ, George J. MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158:1999–2014.e1. - PubMed
    1. Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020;73:202–209. - PubMed
    1. Eslam M, Alkhouri N, Vajro P, Baumann U, Weiss R, Socha P, et al. Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement. Lancet Gastroenterol Hepatol. 2021;6:864–873. - PubMed
    1. Eslam M, Sarin SK, Wong VW, Fan JG, Kawaguchi T, Ahn SH, et al. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int. 2020;14:889–919. - PubMed
    1. Shiha G, Alswat K, Al Khatry M, Sharara AI, Örmeci N, Waked I, et al. Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa. Lancet Gastroenterol Hepatol. 2021;6:57–64. - PubMed